Fortis Healthcare Limited has informed the Exchange about Credit Rating
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CRISIL Ratings has reaffirmed Fortis Healthcare's long-term rating at 'CRISIL AA+/Stable' and short-term rating at 'CRISIL A1+' for bank facilities worth Rs. 425.98 crore and non-convertible debentures of Rs. 1,550 crore. The reaffirmation follows a prior upgrade in September 2025 from 'CRISIL AA/Stable' to 'CRISIL AA+/Stable'. In H1 FY26, consolidated revenue grew 17% year-on-year to Rs. 4,498 crore, with EBITDA margin improving 300 basis points to 23.3%. The company operates 33 hospitals across 11 states with 5,700+ beds, and revenue is projected to cross Rs. 10,000 crore with operating margins of 22-25% over the medium term.
The rating reaffirmation at the high investment-grade level of AA+ signals continued strong credit quality and financial health, which is positive for shareholders. This suggests stable borrowing costs and reflects the company's strong market position, improving profitability, and comfortable debt metrics despite ongoing expansion plans.